marcus evans north america conferences

Clinical Risk Based Monitoring

Incorporating a Fully Operational Risk Based Monitoring Structure to Achieve Greater Trial Performance

5-6 Dec 2017
Philadelphia, PA, United States of America


Why You Should Attend

Clinical Risk Based Monitoring

As biopharmaceutical companies continue to retain a reliance on data analytics, they possess an increase capability to actively assess and continuously monitor trial sites, overall quality and patient safety, as well as outcomes. Risk-based monitoring is now the industry standard to achieve safer and improved trial outcomes which is now leading organizations in the industry to proactively examine how to effectively incorporate and transform into a fully operational RBM trial structure.

This premier marcus evans event will bring together the foremost leaders in Risk Based Monitoring, Clinical QMS, Clinical Safety and Clinical Trial Management to explore ways to reduce costs while enhancing overall trial quality, data, and outcomes through a more risk based approach.

Key Topics

  • Enhance sponsor oversight, CROs and quality systems to proactively mitigate risk, and ensure patient safety
  • Streamline trial costs through centralization of monitoring practices
  • Ensure compliance with existing and forthcoming regulations to avoid negative impacts
  • Identify the latest tools and technologies that advance risk based monitoring and clinical safety
  • Evaluate new methodologies for clinical trials to ensure safe and effective global trial design

    • Previous Attendees Include

    Cubist Pharmaceuticals, Bristol Myers Squibb, Eli Lilly & Co, Roche Diagnostics Corporation, Takeda Pharmaceuticals USA, GlaxoSmithKline, Jansen R&D, Pfizer, Bayer Healthcare, Genentech USA Inc, Johnson & Johnson, Purdue Pharma, CSL Behring, Novo Nordisk Inc, Watson Pharmaceuticals, Vertex Pharmaceuticals Inc, Merck, Amicus Therapeutics, Biogen, Genzyme, UCB, INC Research, Rho Inc., Alnylam Pharmaceuticals, Snow Companies, Leadiant Biosciences Inc., Baxter International Inc., Exelixis, Edwards LifeSciences, Quintiles IMS, Shire, AbbVie, Amicus Therapeutics, FDA, Pfizer, National Health Council (NHC), Patients Rising, Achillion Pharmaceuticals, Inc., American Cancer Society Cancer Action Network, Inc., BioMarin, American Heart Association, Otsuka Pharmaceutical Companies, Biotechnology Innovation Organization (BIO), EMD Serono, and many more!


    Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.




    Event Partners


    Practical Insights From

    Jonathan Rowe PhD
    Executive Director, Head of Quality Performance and Risk Management
    Pfizer, Inc.

    Michael Walega
    Head of Centralized Monitoring
    Bristol-Myers Squibb

    Matthew Krumrai
    Director, Clinical Quality Assurance
    AbbVie

    Adrienne Strickler
    Associate Director, Risk Management-Central Monitoring
    Janssen R&D

    Patricia Cataruozolo, PhD, MS, BSN
    Director, Clinical Site Management
    Pfizer, Inc.

    Darin Oppenheimer
    Executive Director, Head Drug Device Center of Excellence
    Merck

    Georgie Mathew
    Director BioResearch Quality & Compliance
    Johnson & Johnson

    Ralph Mazenko
    Director, GCP Quality Improvement
    Regeneron Pharmaceuticals, Inc.

    Click Here For Full Agenda

    Voice of Our Customers
    • “Very informative and interesting. I’m impressed with the knowledge of the speakers.” - Allergan
    • “Diverse, well organized presentations by experience people.” - AbbVie
    • “High quality presentations, engaged audience, well-run” - GSK Consumer
    • “I continue to be impressed by the quality of speakers and depth of content at each marcus evans event.” - AstraZeneca
    • “Well organized and complementary content & speakers.” - Duke Clinical Research Institute
    Join the Discussion

    Follow on LinkedIn





    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    Deborah Sacal

    The NBC Tower, 9th Floor
    455 N Cityfront Plaza Drive
    Chicago, IL 60611

    Telephone:     312.894.6347
    Fax: 312.894.6347
    Email: Alejandrad@marcusevansch.com